Lions Gate Shares Following Merger and Private Placement

Lions Gate Shares Following Merger and Private Placement 


MAHWAH, N.J., Dec. 9  /PRNewswire-FirstCall/ -- Lions Gate Investment Limited
(Lions Gate) (LGIV.OB) announced today that immediately following the closing of
the merger and the first tranche of the private placement described in the
company press release of this same date, Lions Gate had outstanding 37,661,650
shares of common stock, warrants to purchase 16,093,770 shares of Lions Gate
common stock, and stock options to purchase 1,472,000 shares of Lions Gate
common stock.

Forward Looking Statements

This release contains certain "forward-looking statements," relating to the
business of DOBI Medical, which can be identified by the use of forward-looking
terminology such as "believes," "expects," or similar expressions.  Such forward
looking statements involve known and unknown risks and uncertainties, including
uncertainties relating to product development, regulatory actions or delays, the
ability to obtain or maintain patent or other proprietary intellectual property
protection, market acceptance, physician acceptance, third party reimbursement,
future capital requirements, competition in general and other factors that may
cause actual results to be materially different from those described herein as
anticipated, believed, estimated or expected.  Certain of these risks and
uncertainties are or will be described in greater detail in our filings with the
Securities and Exchange Commission.  DOBI Medical Systems is under no obligation
(and expressly disclaims any such obligation) to update or alter its
forward-looking statements whether as a result of new information, future events
or otherwise. 

DATASOURCE: DOBI Medical Systems, Inc.



CONTACT:  Michael Jorgenson, Executive Vice President of DOBI Medical

Systems, Inc., [phone], or Fax, [phone]



Web site:  http://www.dobimedical.com/ 

Copyright